Associated Papers
Thoracic chordoma following intracranial meningioma in a patient with a novel germline SMARCE1 variant.
Tsurubuchi T et al.
European Journal of Medical Genetics, 2026
Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma.
Umbaugh CS et al.
Science Advances, 2025
The TBXT rs2305089 SNP links the benign notochordal cell tumour and chordoma.
Usher I et al.
The Journal of Pathology, 2025
Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy.
Newman JA et al.
Nature Communications, 2025
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
39991480 (PubMed )
Supplement: mmc5.xlsx › Sheet1
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
Passeri T et al.
Journal of Neurosurgery, 2023
Association between TBXT rs2305089 polymorphism and chordoma in Iranian patients identified by a developed T-ARMS-PCR assay.
Jalessi M et al.
Journal of Clinical Laboratory Analysis, 2022
Multiple malignant tumors in a patient with familial chordoma, a case report.
Sumransub N et al.
Bmc Medical Genomics, 2021
Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death.
Cottone L et al.
Cancer Research, 2020
Small-molecule targeting of brachyury transcription factor addiction in chordoma.
Sharifnia T et al.
Nature Medicine, 2019
Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
Bosotti R et al.
Scientific Reports, 2017
The brachyury Gly177Asp SNP is not associated with a risk of skull base chordoma in the Chinese population.
Wu Z et al.
International Journal of Molecular Sciences, 2013
Select a paper to view details